Advances in Cancer Treatment by Targeting the Neddylation Pathway

被引：30
|
作者：
Gai, Wenbin [1 ,2 ]
Peng, Zhiqiang [3 ]
Liu, Cui Hua [4 ]
Zhang, Lingqiang [1 ,2 ,3 ,5 ]
Jiang, Hong [1 ,2 ]
机构：
[1] Qingdao Univ, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Sch Basic Med, Dept Physiol,Med Coll, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Basic Med, Med Coll, State Key Disciplines Physiol, Qingdao, Peoples R China
[3] Beijing Inst Lifeom, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China
[4] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China
[5] Peixian Peoples Hosp, Xuzhou, Jiangsu, Peoples R China
来源：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金：
中国国家自然科学基金;
关键词：
developmental down-regulation protein 8 (NEDD8); neddylation; MLN4924; treatment; cancer;
D O I：
10.3389/fcell.2021.653882
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Developmental down-regulation protein 8 (NEDD8), expressed by neural progenitors, is a ubiquitin-like protein that conjugates to and regulates the biological function of its substrates. The main target of NEDD8 is cullin-RING E3 ligases. Upregulation of the neddylation pathway is closely associated with the progression of various tumors, and MLN4924, which inhibits NEDD8-activating enzyme (NAE), is a promising new antitumor compound for combination therapy. Here, we summarize the latest progress in anticancer strategies targeting the neddylation pathway and their combined applications, providing a theoretical reference for developing antitumor drugs and combination therapies.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] The Double-Edged Effects of MLN4924: Rethinking Anti-Cancer Drugs Targeting the Neddylation Pathway
    Tang, Haoming
    Pang, Xin
    Li, Shun
    Tang, Liling
    BIOMOLECULES, 2024, 14 (07)
  • [32] Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
    Pramanik, Nilkamal
    Gupta, Aditya
    Ghanwatkar, Yashwardhan
    Mahato, Ram I.
    JOURNAL OF CONTROLLED RELEASE, 2024, 366 (231-260) : 231 - 260
  • [33] Targeting the STAT pathway in head and neck cancer: Recent advances and future prospects
    Nikitakis, NG
    Siavash, H
    Sauk, JJ
    CURRENT CANCER DRUG TARGETS, 2004, 4 (08) : 637 - 651
  • [34] Current advances of targeting HGF/c-Met pathway in gastric cancer
    Anestis, Aristomenis
    Zoi, Ilianna
    Karamouzis, Michalis V.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (12)
  • [35] Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer
    Kyriakopoulou, Konstantina
    Kefali, Elena
    Piperigkou, Zoi
    Bassiony, Heba
    Karamanos, Nikos K.
    CELLULAR SIGNALLING, 2018, 51 : 99 - 109
  • [36] Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development
    You, Weon-Kyoo
    Schuetz, Thomas J.
    Lee, Sang Hoon
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (01) : 3 - 11
  • [37] Disulfiram overcomes docetaxel resistance in prostate cancer by targeting the neddylation pathway and down-regulation of Skp2 expression
    Song, Liankun
    Yu, Bin
    Liu, Hong-Min
    Zi, Xiaolin
    CANCER RESEARCH, 2018, 78 (13)
  • [38] Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
    Xu, Junfeng
    Li, Zheng
    Zhuo, Qifeng
    Ye, Zeng
    Fan, Guixiong
    Gao, Heli
    Ji, Shunrong
    Yu, Xianjun
    Xu, Xiaowu
    Liu, Wensheng
    Xu, Wenyan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer
    Hadden, M. K.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (35) : 4031 - 4032
  • [40] Targeting the MYC activation and degradation pathway for the treatment of pancreatic cancer
    Farrell, Amy S.
    Allen-Petersen, Brittany
    Daniel, Colin J.
    Wang, Xiaoyan
    Wang, Zhiping
    Christensen, Dale J.
    Sheppard, Brett
    Sears, Rosalie C.
    CANCER RESEARCH, 2015, 75
12345